Skip to main content
Fig. 3 | Diagnostic Pathology

Fig. 3

From: Concomitant novel ALK-SSH2, EML4-ALK and ARID2-ALK, EML4-ALK double-fusion variants and confer sensitivity to crizotinib in two lung adenocarcinoma patients, respectively

Fig. 3

Timeline of the case 2’s disease from diagnosis to death (A). Chest computed tomography (CT) scans at diagnosis (B), and brain magnetic resonance imaging images at baseline (upper panel) and after crizotinib treatment (lower panel) (C). The yellow arrow indicates a new meningeal metastasis lesion

Back to article page

Diagnostic Pathology

ISSN: 1746-1596

Contact us